Question explored with the scientific record
shingles vaccine vs regular exposure to chick pox for preventing shingles
The short version: the shingles vaccine is a targeted booster for older adults, while natural chickenpox exposure does not appear to protect against shingles in the way the old theory predicted.
The idea that regular contact with children who have chickenpox keeps your immunity boosted and prevents shingles is not supported by the best evidence. A large 2010 case-control study of over 1,200 adults found that the number of varicella contacts in the previous 10 years was not associated with a lower risk of shingles [3]. Even three or more contacts showed no protective trend [3]. A 2007 national survey of older adults also found that past-decade chickenpox exposure was not protective [2].
The shingles vaccine, particularly the recombinant version (Shingrix), works differently. It is a direct, high-dose booster of your immune memory against the virus. In clinical trials, two doses showed about 97% efficacy against shingles in adults aged 50 and older, with protection lasting above 84% even 8 years later [1]. Real-world effectiveness in older Medicare beneficiaries is lower, around 70% after two doses, but still substantial [1]. The vaccine does carry a small risk: about 3 extra cases of Guillain-Barré syndrome per million doses [1].
| Prevention Strategy | How It Works | Protection Against Shingles |
|---|---|---|
| Natural chickenpox exposure | Indirect, unpredictable boosting | None detected in studies [2, 3] |
| Shingles vaccine (RZV) | Direct, high-dose immune booster | ~70-97% efficacy depending on age and setting [1] |
The old theory that natural exposure keeps the virus in check has been tested and failed. The vaccine is a deliberate intervention that works, but it is not risk-free. For an older adult, the vaccine offers a clear benefit that natural exposure does not.
My call: the shingles vaccine is a proven intervention for older adults, while relying on natural chickenpox exposure for protection is not supported by the evidence. Confidence: high.
Sources used 3
-
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
This narrative review finds real-world vaccine effectiveness of about 46% for live zoster vaccine and about 85% for recombinant zoster vaccine, with mostly local reactions and a small Guillain-Barré syndrome signal to monitor.
DOI: 10.3390/v14122667 -
Chickenpox Exposure and Herpes Zoster Disease Incidence in Older Adults in the U.S.
Among U.S. adults aged ≥65 in 2004, self-reported herpes zoster incidence was 19 per 1,000 per year, higher than previous U.S. estimates; whites had higher incidence than Hispanics, and past-decade chickenpox exposure was not protective.
DOI: 10.1177/003335490712200204 -
Herpes Zoster and Exposure to the Varicella Zoster Virus in an Era of Varicella Vaccination
In a case-control study of 1,288 adults aged 40-79 years, prior contacts with varicella, zoster, or children were not associated with herpes zoster, with no protective trend at 3 or more varicella contacts.
DOI: 10.2105/ajph.2009.160002